Drug Market Growth in China to Accelerate to Up to 25% This Year, Lu Says

China’s pharmaceuticals market growth will accelerate to 20 percent to 25 percent this year, spurred by rising government spending and increased investment from multinational drugmakers, according to Katherine Lu, director of China equities at Oppenheimer & Co.

“Investment is long overdue,” Lu, who covers health-care companies for the New York brokerage, said in a phone interview. “China is expected to become the third-largest health-care market by next year according to the IMF, that’s ahead of projections that this would happen by 2013.”

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.